MedTrace Logo

Homocysteine After Nitrous Oxide Anesthesia

NCT00482456 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2007-06-05

No results posted yet for this study

Summary

Our study looks at the interaction of a common mutation in the MTHFR gene and the risk of developing higher homocysteine levels after nitrous oxide (N2O) anesthesia.

Specifically, we want to test the hypothesis that healthy patients carrying the MTHFR 677C\>T haplotype develop abnormal homocysteine levels after nitrous oxide anesthesia.

Conditions

  • Anesthesia, General
  • Adverse Effects
  • Nitrous Oxide

Interventions

DRUG

Nitrous oxide

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Peter Nagele, M.D. · Medical University of Vienna

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2007-03-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00482456 on ClinicalTrials.gov